Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Seeing Medicines
AddedFeb 15, 2024
UpdatedJun 18, 2026
Seeing Medicines

Seeing Medicines

Series A

Seeing Medicines: A biotech firm innovating regenerative treatments for vision restoration.

HQ
Arden, NC, US
Founded
2020
Overview
Compare
Fundraising
Employees

Seeing Medicines is a biotech company dedicated to developing regenerative ocular treatments aimed at restoring and maintaining vision in individuals with macular degenerative diseases, including Age-related Macular Degeneration (AMD), Best Disease, and Stargardt Disease. Founded in 2020 and based in Arden, NC, the company's mission is to leverage regenerative medicine to combat vision loss.

Since its inception, Seeing Medicines has made significant strides in the field of regenerative medicine for ocular health. The company has developed promising treatment candidates that have shown potential in preclinical studies. Their innovative approach has garnered attention from key stakeholders in the biotech and medical communities.

Seeing Medicines - Similar Companies

Oculogenex logo

Oculogenex

oculogenex.com

Vision Medicines logo

Vision Medicines

EyeCyte logo

EyeCyte

eyecyte.com

Visiox logo

Visiox

visioxpharma.com

Endogena Therapeutics logo

Endogena Therapeutics

Caeregen Therapeutics logo

Caeregen Therapeutics

caeregen.com

Perceive Biotherapeutics logo

Perceive Biotherapeutics

perceivebio.com

Imagen Biotech logo

Imagen Biotech

ReVision Therapeutics logo

ReVision Therapeutics

Neumedics logo

Neumedics

Ocular Science logo

Ocular Science

ocularscience.com

Aldeyra Therapeutics logo

Aldeyra Therapeutics

Juventas Therapeutics logo

Juventas Therapeutics

juventasinc.com

Sight Sciences logo

Sight Sciences

sightsciences.com

Ocudyne logo

Ocudyne

ocudyne.com

Seeing Medicines - Quick Facts

Who are Seeing Medicines' competitors?

Companies similar to Seeing Medicines include Oculogenex, Vision Medicines, EyeCyte and Visiox.

When was Seeing Medicines founded?

Seeing Medicines was founded in 2020.

Where is Seeing Medicines' headquarters located?

Seeing Medicines' headquarters is located in Arden, NC, US.

When was Seeing Medicines' last funding round?

Seeing Medicines' most recent funding round was for $6.9M (USD) in June 2021.

How much has Seeing Medicines raised to-date?

As of Jun 28, 2021, Seeing Medicines has raised a total of $6.9M (USD).

How many employees does Seeing Medicines have?

Seeing Medicines has 7 employees as of Feb 5, 2024.

Seeing Medicines - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Customer
  • Enterprise
  • Small Business
Main Product
  • Regenerative Medicine
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 12 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research